Moon Surgical obtains CE Mark certification for its commercial Maestro System
Moon Surgical has unveiled that the most recent iteration of its Maestro System has obtained the CE Mark certification in accordance with the Medical Device Regulation (EU) 2017/745.
In addition to its enhanced scalability and refined aesthetics, this updated Maestro System boasts several enhancements compared to its predecessor, including:
1. Streamlined setup procedures with automated guidance at the bedside and personalized surgeon configurations.
2. Integration with cloud technology for a more cohesive Maestro Operating Room (OR) experience and ecosystem.
3. Hands-free scope control under the guidance of surgeons, enhancing visual capabilities.
“This latest evolution of the Maestro System focuses on manufacturing scalability, together with increased capability and has simplified both usability and training,” said Anne Osdoit, CEO of Moon Surgical, and a Partner at Sofinnova Partners. “It seamlessly integrates into OR workflows while giving surgeons more confidence and delivering an improved surgical experience.”
With its innovative category of robotic surgery, Moon Surgical aims to not only expand the utilization of robotics but also elevate the standard of care for patients and bolster the financial performance of healthcare providers. The Maestro System is engineered to offer an accessible and enhanced alternative to traditional laparoscopy for the more than 18 million patients who undergo soft tissue procedures annually, currently deprived of the advantages offered by robotic surgical platforms.
The initial iteration of the Maestro System had previously obtained its CE Mark certification in April earlier this year.
© Moon Surgical